Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stent graft under scrutiny for aortic repair in japan

NCT ID NCT07049913

Recruiting now Disease control Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well a device called the GORE® TAG® Thoracic Branch Endoprosthesis works for people with a thoracic aortic aneurysm, dissection, or injury. About 200 patients in Japan who receive this stent graft will be followed to see if it is safe and effective. The main goals are to ensure the device can be placed successfully and to track any serious complications like stroke, paralysis, or device problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GORE® TAG® Thoracic Branch Endoprosthesis (a stent graft device placed in the aorta to repair damage)
What this could lead to
If successful, this could confirm that the device is a safe and effective option for treating serious aortic conditions in the chest.
What could go wrong
This is a post-market surveillance study, not a randomized trial, so results may not apply to all patients. Risks include stroke, paralysis, kidney failure, or device complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM THORACIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aortic Dissection injury spinal cord injury thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEURYSM THORACIC DISSECTION OF AORTA, THORACIC TRAUMA

Contacts and locations

Locations

  • The University of Osaka Hospital

    RECRUITING

    Osaka, Suita, 565-0871, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.